Navigation Links
Oracle Focuses on Health Sciences Partner Enablement, Growth, and Accreditation
Date:6/22/2009

sp" target="_new">Cognizant. "Oracle's flexible training and enablement model will make it easier for our clients to achieve greater value and satisfaction from Oracle Health Sciences applications."
  • "The combination of Oracle's best-in-class applications for the life sciences sector and its commitment to supporting our business with high quality education and training materials is delivering measurable value not only to us, but also to our customers," said Robin Kearon, CEO, Business & Decision North America. "With the support of Oracle Health Sciences, we are helping our customers achieve an optimum delivery strategy that is resulting in superior performance, appropriately managed risks and significant cost savings."

    • Supporting Resources

    About Oracle

    Oracle (Nasdaq: ORCL) is the world's largest business software company. For more information about Oracle, please visit our Web site at http://www.oracle.com.<
    '/>"/>

    SOURCE Oracle Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4

    Related medicine news :

    1. Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry
    2. The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite
    3. Oracle Buys Relsys
    4. Sermes CRO Deploys Oracle(R) Clinical Applications to Support Growth
    5. Vgo Software First to Convert Oracle Forms to Oracle ADF v11
    6. MedTrust Online Collaborates With Oracle and Dell to Provide Oncologists With the Next Generation Tool for Personalized Care Delivery
    7. Oracle Healthcare Acquisition Corp. Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation
    8. Oracle Healthcare Acquisition Corp. Changes Record Date and Date of Special Meeting to Consider and Vote on Dissolution and Plan of Liquidation
    9. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
    10. Oracle Introduces Remote Data Capture Onsite 4.5.3 With Extensive New Functionality for Investigative Site Personnel
    11. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/23/2009)... After suffering from women,s hair loss...rowing back and she,s sharing her progress and the... women through the release of her video diaries wh... and during her treatment. , ...r loss sufferer Zsanett Siklosi has released the ...
    (Date:11/23/2009)...he-job interaction might ease the problem, researc...News) -- Men who bottle up their anger over unfair...a new Swedish study indicates. , Men who consis...flicts with a fellow worker or supervisor were mor...ie of heart disease as those who vented their ange...
    (Date:11/23/2009)...O,Pa.,Nov.23/PRNewswire-FirstCall/--InfoLogix,Inc....risemobilitysolutionsforthehealthcareandcommercial...identofManagedServicesatSiemensHealthServices,hasj...Services. ,, (Logo: http://www.newscom.com/cgi-...entofStrategicHealthcareServicesforInfoLogix,Mr.Wa...
    (Date:11/23/2009)...GTON,Nov.23/PRNewswire-USNewswire/--TheAmericanSoc...en,spublishing,education,andmediacompany,arelaunch...culumdesignedtosparkinterestinthefieldsofsciencean...reeropportunitiesinhematology. ,, "Manyhematolo...HemotheMagnificent,whichmadelearningaboutbloodreal...
    (Date:11/23/2009)...rs of cancer patients and survivors treated with c...t often become chronic conditions, hindering patie...ists at the University of Rochester Medical Center...xperienced sleep troubles at nearly three times th...more prevalent in younger patients and those with ...
    Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2
    ...hers have observed that there is evidence which sh...t way forward in peripheral arterial disease. Arou...e affected by peripheral arterial disease (PAD), a...ink walking would be the worst thing you could do....
    ...rved that a drug already being used to treat a rar...ontraceptive. Researchers hypothesized N-butyldeox...n Europe to treat Gaucher's disease, might work// ...tudy involving mice. The mice were given doses of ...
    ...a large survival benefit in taking cholesterol-low...in Munich have studied the effect of taking simvas... at a group of 72 patients who had had heart trans...erol diet. Later, they too went on the statin drug...
    ...hat filters toxins from the blood can buy a patien... failure is a relatively common problem and most o...livers are in short supply and many patients die w...n elusive. However, researchers at the Unive...
    ...as been observed that approximately two thirds of ...girls in juvenile detention suffer from at least//...3 juvenile teens were interviewed and evaluated by...er to track the prevalence of psychiatric disorder...
    ...aced by the middle aged people. There are many rea...ife, but simple guidelines can help you preserve m...n undergo a decline// in their memory or thinking ...ay there are many possible reasons for this - stre...
    Other Medicine News:
    (Date:11/23/2009)...stCall/--AMICAS,Inc.(Nasdaq: AMCS ),aleaderinimage...atitwillhighlightitsenterpriseimagingautomationsol...SNA)annualmeetingfromNovember29toDecember4inChicag... (Logo: http://www.newscom.com/cgi-bin/prnh/200602...nabouthealthcarereform,thereisanunprecedentedinter...
    (Date:11/23/2009)...ePointMedicalannouncedtodaythatitreceivedEuropeanC...ralChronicTotalOcclusion(CTO)CrossingSystemcompris...ray®CTORe-EntrySystem.TheBridgePointSystemisa...vigatehighlydiseasedarteriesinpreparationforbloodf...NationalHeart,LungandBloodInstitute(NHLBI)estimate...
    (Date:11/23/2009)...stCall/-- CumberlandPharmaceuticalsInc. (CPIX) to...evaluatingthesafetyandefficacyofCaldolor( ibuprofe...nts. ,, Statisticalsignificancewasachievedforth...hefirst24hoursoftreatment.Thestudyevaluated61adult...rethan10percenttotalbodysurfacearea.Otherparticipa...
    Breaking Medicine Technology:AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 2AMICAS' Enterprise Imaging Solutions Highlighted at RSNA 2009 3BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures 60497 1Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures 60497 2Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures 60497 3New Shire Board Member 14680 1New Shire Board Member 14680 2Nuevolution Announces Receipt of Milestone Payment From Merck 26amp 3B Co Inc 5896 1Nuevolution Announces Receipt of Milestone Payment From Merck 26amp 3B Co Inc 5896 2
    ...ralia, Sept. 17 Phosphagenics,Limited (ASX: POH, ...owing,successful preclinical studies, it plans to ... trial aimed at providing chronic pain sufferers w...Phosphagenics has submitted all necessary document...ted at CMAX - an independent clinical research,org...
    ...tudy Safety and Efficacy of Tengion,s Neo-Bladder ...y Patients, EAST NORRITON, Pa., Sept. 17 Tengion...ed today it has initiated a Phase 2,multi-center c...d from a,patient,s own cells. The U.S.-based study...ogenic bladder due to spinal cord injuries. Neurog...
    Other Medicine Technology:Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial 2Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 2Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 3
    Centrifuge 4-15C *Avaiable in Europe and Australia*
    ...l 5415D is an ideal workhorse for the lab, featuri...of time and speed/g-force. , Product features ,..., Compact 9 x 12-inch (W x D) footprint fits on ...apacity , Brushless motor provides maintenance-...
    ...Model EXD explosion-proof laboratory floor model c...ion-proof apparatus. EXD is suitable for use in Cl... "atmospheres containing gasoline, petroleum, naph...s.", Adherence to these specifications is so stri...
    XCell SureLock Mini-Cell and XCell II Blot Module Kit CE Mark
    Medicine Products: